Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-03-18, Stock:LLY, The news for the past five days is as follows:
2021-03-11: NEWS1: Special Report: Insider alleges Eli Lilly blocked her efforts to sound alarms about U.S. drug factory.
2021-03-12: nan
2021-03-15: NEWS1: Eli Lilly Said Its Alzheimer’s Data Were Positive. The Stock Market Says Otherwise..NEWS2: Eli Lilly Fails To Stun Investors As Alzheimer's Drug Shows Mixed Impact.NEWS3: Eli Lilly Fails To Stun Investors As Alzheimer's Drug Shows Mixed Impact.NEWS4: Dow Jones Reverses Off New High As Stock Market Falters; Why Airlines Are Soaring.NEWS5: Why Eli Lilly Stock Is Sinking Today.NEWS6: Stock Market Today With Jim Cramer: How to Trade Eli Lilly.NEWS7: Eli Lilly Shares Fall After Alzheimer’s Drug Data Falls Short Of High Expectations.NEWS8: Eli Lilly's Stock Is Trading Lower After Donanemab Showed Mixed Data In Mid-Stage Alzheimer's Study.NEWS9: Why Eli Lilly's Successful Alzheimer's Disease Study Was So Disappointing.NEWS10: Lilly's stock is down after sharing additional clinical data about its Alzheimer's disease drug candidate.NEWS11: US STOCKS-Futures buoyed by optimism over U.S. economic growth.NEWS12: Premarket Movers Monday - American Airlines, Eli Lilly, XPeng, AMC.NEWS13: Eli Lilly Surges On Positive Data From Key Trial of Alzheimer's Treatment.NEWS14: Eli Lilly Shares Slump After Mixed Data From Alzheimer's Drug Trial.
2021-03-16: NEWS1: Eli Lilly's Mirikizumab Beat Placebo At Controlling, Resolving Ulcerative Colitis Symptoms.NEWS2: Lilly (LLY) Down as Alzheimer's Drug Fails Investor Expectation.NEWS3: Dip in Eli Lilly Stock Makes It a Buy, Mizuho Analyst Says.NEWS4: The Zacks Analyst Blog Highlights: MGM Resorts, American Airlines, Blackstone Group, Extended Stay America and Eli Lilly.NEWS5: AstraZeneca to supply U.S. with extra 500,000 doses of COVID-19 antibody-based cocktail.NEWS6: UPDATE 1-Eli Lilly bowel disease treatment succeeds in late-stage study.NEWS7: Lilly's Mirikizumab Helps Patients Achieve Clinical Remission and Improves Symptoms in Adults with Ulcerative Colitis in 12-Week Phase 3 Induction Study.
2021-03-17: NEWS1: Lilly (LLY) Mirikizumab Meets Ulcerative Colitis Study Goal.NEWS2: Lilly Presents Patient-Reported Outcomes from the Positive Phase 3 monarchE Trial for Verzenio® at St. Gallen Virtual Congress 2021.NEWS3: 4 Pharma Stocks That Could Be Losers With the $1.9 Trillion Stimulus Package.

Answer: Decrease